Humana Inc. reports news around its U.S. healthcare business, combining Humana insurance services with CenterWell healthcare services. Company updates commonly address Medicare Advantage and other health plan membership, Insurance segment benefit ratios, GAAP and adjusted earnings, full-year guidance, and capital returns through quarterly dividends.
News also covers CenterWell's senior-focused primary care, home health, pharmacy, hospice and retail pharmacy activities; prescription access and home delivery partnerships; healthcare research tied to medication adherence and chronic disease care; palliative care arrangements; health data interoperability; and board refreshment or other governance actions.
Humana Specialty Pharmacy has been awarded the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the fifth consecutive year, highlighting its strong commitment to customer satisfaction and patient care. The award reflects the dedication of its staff, including pharmacists and care coordinators, in providing personalized care. Humana Specialty Pharmacy offers 24-hour access to pharmacists and supports patients applying for assistance programs for specialty drugs. Humana Inc. (NYSE: HUM) aims to improve health outcomes for its members through integrated care solutions.
Humana Inc. (NYSE: HUM) announced that CFO Susan M. Diamond will present at the BofA Securities Healthcare Conference on May 10, 2022, at 9:20 a.m. Pacific time. A live audio webcast will be accessible through Humana’s Investor Relations page, with participants encouraged to log in 15 minutes early for setup. Humana focuses on integrated care to improve health outcomes and lower costs for members, offering services in in-home care, behavioral health, and more. Additional information is available at humana.com.
Humana reported strong 1Q22 earnings with a GAAP EPS of $7.29 and an Adjusted EPS of $8.04, both exceeding previous year figures. The company raised FY 2022 EPS guidance to approximately $22.98 on a GAAP basis and $24.50 on an Adjusted basis, reflecting a 19% growth from FY 2021, despite a COVID-19 headwind. Humana anticipates membership growth of 150,000 to 200,000 in Medicare Advantage for FY 2022 and has introduced a $1 billion value creation initiative to enhance services. Total revenues rose to $23.97 billion from $20.67 billion year-over-year.
Humana Inc. has entered into a definitive agreement to divest a 60% interest in its Hospice and Personal Care divisions of Kindred at Home to Clayton, Dubilier & Rice for approximately $2.8 billion. This transaction reflects a valuation of $3.4 billion and a multiple of about 12 times the divisions’ forecasted Adjusted EBITDA. The move aligns with Humana's strategy to offload non-core segments while still maintaining a minority interest. Proceeds will be used for debt repayment and share repurchases, with no significant impact on 2022 earnings expected.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.7875 per share, payable on July 29, 2022, to stockholders of record as of June 30, 2022. This dividend reflects the company's commitment to providing value to its shareholders while maintaining a robust financial position. Humana focuses on integrated care solutions aimed at improving health outcomes and lowering costs for its members, contributing to a better quality of life for various communities.
Humana Inc. (NYSE: HUM) has released its 2021 Impact Report, underlining its commitment to Environmental, Social, and Governance (ESG) initiatives. The report highlights significant investments, including over $15 million in caregiver support and an 32% increase in primary care centers to 206. Humana conducted 94,000 medical screenings, serving 1.6 million meals to members in need and achieving 16% reduction in greenhouse gas emissions. The company aims to enhance transparency in future ESG reporting as part of its business strategy.
Humana Inc. (NYSE: HUM) announced a new $25 million investment to enhance affordable housing across the United States, raising its total commitment to $50 million. This investment targets various states including Florida, Georgia, and Illinois, aiming to address housing needs for vulnerable communities. Humana's strategy includes interventions to reduce healthcare costs and improve health outcomes. The funds will be deployed through three syndicated funds utilizing low-income housing tax credits to support construction and rehabilitation of affordable housing.
Humana (NYSE: HUM) hosted the First Pitch, a virtual event linking diverse suppliers with top prime suppliers as part of its Supplier Diversity Mentor Protégé Program. This initiative, active since 2019, aims to enhance opportunities for minority-owned and small businesses. In 2021, Humana invested $345 million in diverse suppliers, a 9% increase from 2020. The event provided participants valuable feedback and potential business opportunities, reinforcing Humana's commitment to fostering relationships that drive innovation and growth.
The Humana Foundation has announced a continued investment of $5.5 million aimed at enhancing health equity outcomes for marginalized populations across six communities in the United States. This initiative, which has spanned over 40 years, focuses on food security, financial wellness, and social connections through local partnerships. Nine organizations will benefit from this funding, which will be allocated based on specific metrics achieved in their respective programs, enhancing community health and wellness for diverse groups.
Humana Inc. (NYSE: HUM) will report its 1Q22 financial results on April 27, 2022, at 6:30 a.m. Eastern time. A conference call will follow at 9:00 a.m. to discuss the results and 2022 earnings guidance. Participants can register in advance for the call via a provided link, and a webcast will be available on Humana's Investor Relations page. The earnings release will include non-GAAP financial measures and a reconciliation to GAAP. Archived presentations will be accessible later on the website.